Melanoma Molecular Profiling Analysis

Exclusion Criteria

• •Serious illnesses that may be considered a contraindication to surgery as determined by the physician investigator. If a subject is cleared for surgery as clinically indicated (wide excision of the primary melanoma and sentinel lymph node biopsy), subject would be eligible.
• •Any significant psychiatric disease, medical intervention, or other condition, which in the opinion of the Principal Investigator or Co-Investigators, could prevent adequate informed consent or compromise participation in the clinical trial.
• •Active infection or antibiotics within one-week prior to study
• •Systemic steroid or other immunosuppressive therapy administered for more than 10 days within 4 weeks of enrollment.